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Abstract
This article describes the frequency of alcohol use among HIV-positive patients attending clinical 
care in sub-Saharan Africa and explores the association between alcohol use, medication 
adherence, and sexual risk behavior. Data from 3538 patients attending an HIV clinic in Kenya, 
Tanzania, or Namibia were captured through interview and medical record abstraction. 
Participants were categorized into three drinking categories: nondrinkers, nonharmful drinkers, 
and harmful/likely dependent drinkers. A proportional odds model was used to identify correlates 
associated with categories of alcohol use. Overall, 20% of participants reported alcohol use in the 
past 6 months; 15% were categorized as nonharmful drinkers and 5% as harmful/likely dependent 
drinkers. Participants who reported missing a dose of their HIV medications [adjusted odds ratio 
(AOR): 2.04, 95% confidence interval (CI): 1.67, 2.49]; inconsistent condom use (AOR: 1.49, 
95% CI: 1.23, 1.79); exchanging sex for food, money, gifts, or a place to stay (AOR: 1.57, 95% 
CI: 1.06, 2.32); and having a sexually transmitted infection symptom (AOR: 1.40, 95% CI: 1.10, 
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1.77) were more likely to be categorized in the higher risk drinking categories. This research 
highlights the need to integrate alcohol screening and counseling into the adherence and risk 
reduction counseling offered to HIV-positive patients as part of their routine care. Moreover, 
given the numerous intersections between alcohol and HIV, policies that focus on reducing 
alcohol consumption and alcohol-related risk behavior should be integrated into HIV prevention, 
care, and treatment strategies.
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Introduction
Sub-Saharan Africa (SSA) continues to bear the burden of the global HIV/AIDS pandemic. 
Accounting for just 12% of the world’s population, SSA contains 68% of the global 
population of people living with HIV (PLHIV) and 70% of all new HIV infections (Joint 
United Nations Programme on HIV/AIDS [UNAIDS], 2011). However, there is increasing 
evidence that HIV incidence is beginning to decline with models from 22 countries in SSA, 
indicating that incidence has decreased by more than 25% since 2001 (UNAIDS, 2011). 
Optimizing and expanding HIV prevention, care, and treatment efforts is essential in order 
to continue this positive trend.
Many countries in SSA with high HIV prevalence also report high levels of hazardous 
alcohol consumption (Fritz, Morojele, & Kalichman, 2010; World Health Organization 
[WHO], 2011). In Namibia, for example, 25% of men and 21% of women are categorized as 
heavy episodic drinkers. In Tanzania, 20% of men reported consuming alcohol five or more 
days per week (WHO, 2004). Alcohol use has been associated with both HIV incidence 
(Geis et al., 2011; Ruzagira et al., 2011; Seeley et al., 2012) and prevalence (Fisher, Bang, & 
Kapiga, 2007; Hahn, Woolf-King, & Muyindike, 2011) along with sexual risk-taking 
behaviors that can lead to HIV transmission and acquisition including multiple sex partners 
(Scott-Sheldon et al., 2012; Weiser et al., 2006), unprotected sex (Shuper, Joharchi, Iriving, 
& Rehm, 2009; Weiser et al., 2006), coercive sex (Woolf-King & Maisto, 2011), and 
transactional sex (Weiser et al., 2006; Woolf-King & Maisto, 2011).
Alcohol use also has negative implications for the health of PLHIV including increased 
levels of depression (Ghebremichael et al., 2009; Nakimuli-Mpungu, Musisi, Katabira, 
Nachega, & Bass, 2011), accelerated HIV disease progression (Baum et al., 2010; 
Ghebremichael et al., 2009), decreased survival (Braithwaite et al., 2007), and severe 
hepatotoxicity among patients on antiretroviral treatment (ART) (Barve et al., 2010). 
Among patients not yet on ART, heavy alcohol consumption has been associated with a 
lower CD4 cell count (Baum et al., 2010; Hahn & Samet, 2010; Samet et al., 2007) and 
shorter time to CD4 count less than 200 cells/mm3, the typical threshold for an AIDS 
diagnosis (Baum et al., 2010). For patients on ART, studies indicate that regular drinkers are 
more likely to have a detectable viral load even after adjusting for adherence (Shacham, 
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Agbebi, Stamm, & Overton, 2011; Wu, Metzger, Lynch, & Douglas, 2011), suggesting that 
alcohol use may impact the metabolism of ART (Hahn & Samet, 2010; Samet et al., 2007).
Alcohol use can lead to poor self-care behaviors including lack of engagement in medical 
care and nonadherence to ART. Researchers in both domestic and international settings have 
found that heavy drinkers are less likely to report initiating ART (Chander, Lau, & Moore, 
2006; Conen et al., 2009; Martinez et al., 2008) and alcohol use has been consistently 
associated with poor ART adherence (Chander et al., 2006; Do et al., 2010; Hahn et al., 
2011; Hendershot, Stoner, Pantalone, & Simoni, 2009). Studies that have examined the 
relationship between alcohol use and ART adherence have identified both a dose–response 
relationship with adherence decreasing as levels of alcohol use increase (Braithwaite et al., 
2005; Chander et al., 2006) and a temporal association with lower adherence following 
episodes of alcohol use (Braithwaite et al., 2005).
There are also clear gender differences in the relationship between alcohol use, sexual risk 
behavior, and HIV medication adherence. Men are more likely to report alcohol use, to drink 
alcohol more frequently, and to be identified as harmful, hazardous, or likely dependent 
drinkers than women (Kalichman, Simbayi, Kaufman, Cain, & Jooste, 2007). Men’s alcohol 
use is associated with sexual risk behavior, including unprotected sex and sex with casual 
partners (Kalichman et al., 2007). Men are also less likely to be adherent to their HIV 
medications than women, and alcohol use is a main reason why men report nonadherence 
(Braitstein et al., 2008; Keiser et al., 2008). In contrast, women are more likely to report 
drinking alcohol with their sex partners (Kalichman et al., 2007). Women’s alcohol use 
places them at a greater risk for experiencing gender-based violence (Browne & Wechsberg, 
2010; Pitpitan et al., 2013) and for engaging in transactional sex (Kalichman et al., 2007). 
These gender differences highlight the different role that alcohol plays in promoting HIV 
risk behavior between men and women.
Despite the well-known dangers of alcohol use among PLHIV, the frequency of alcohol use 
among PLHIV attending clinical care in SSA is unclear as most studies have been conducted 
in the United States or other high-resource settings (Hahn et al., 2011). Since alcohol use has 
been shown to be a significant determinant of both medication adherence and sexual risk 
behavior in these high-resource settings, it is essential to examine the relationship between 
these variables in SSA where both HIV prevalence and alcohol consumption rates are high. 
In the current study, we describe the frequency of alcohol use among a large, multicountry, 
clinic-based sample of HIV-positive patients attending HIV clinical care in Kenya, Namibia, 
and Tanzania. In order to capture a more comprehensive understanding of alcohol use and 
its relationship with adherence and sexual risk behavior, we examined multiple constructs of 
drinking including frequency, quantity, and severity. The findings from this study will help 
inform the development of more effective and feasible HIV prevention strategies for PLHIV 
attending clinical care in these settings.
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Study population and design
Data presented are from the baseline assessment of a cluster-randomized controlled trial 
conducted in Kenya, Tanzania, and Namibia. The primary objective of the study was to 
examine the feasibility and effectiveness of integrating HIV prevention services into routine 
HIV clinical care in these countries. All three countries have generalized HIV epidemics 
with prevalence rates of 6.2%, 5.7%, and 13.5%, respectively (Kenya National AIDS 
Control Council, 2012; Republic of Namibia Ministry of Health and Social Services, 2012; 
Tanzania Commission for AIDS, 2012). In each country, six clinics were paired on key 
characteristics (e.g., patient volume, provider/patient ratio, services offered) and then 
randomly assigned to either an intervention or control arm.
At each of the 18 study clinics, a representative sample of approximately 200 sexually active 
patients was enrolled between October 2009 and April 2010 as part of an evaluation cohort 
to assess the effectiveness of the clinic-level intervention (Kidder et al., 2013). To be 
eligible, participants had to have an HIV-positive diagnosis, have received care at the project 
clinic at least twice prior to enrolment, be at least 18 years of age, report sexual activity 
within the past 3 months, and plan to attend the clinic for at least 1 year. Women who knew 
they were pregnant at the time of enrollment and male partners of women pregnant at time 
of enrollment were excluded from the study.
Participants provided written informed consent to complete three interviews during the study 
(at baseline and 6- and 12-months postintervention), allow data to be abstracted from their 
medical charts, and to provide contact information for participant tracking during the follow-
up period. This article presents results from the baseline interviews. The protocol for this 
study was approved by the Institutional Review Board at the Centers for Disease Control 
and Prevention and ethics review committees in each country and at all collaborating 
organizations.
Measures
Outcome measures—The WHO’s 10-item Alcohol Use Disorders Identification Test 
(AUDIT) (Babor, Higgins-Biddle, Saunders, & Monteiro, 2001) was used to categorize 
participants into three drinking categories: nondrinkers (AUDIT= 0), nonharmful drinkers 
(AUDIT= 1–7), and harmful/likely dependent drinkers (AUDIT ≥ 8). Participants were 
categorized as “binge drinkers” if they reported having six or more drinks during one 
occasion in the past 6 months. Participants were asked to report all types of alcohol use 
including both traditional brews and commercial alcohols. The AUDIT has been widely 
used and validated in a variety of settings throughout SSA (Kalichman, Simbayi, Jooste, 
Cain, & Cherry, 2006; Luchters, et al., 2011; Nakimuli-Mpungu et al., 2012; Peltzer & 
Ramlagan, 2009; Zetola et al., 2012).
Independent measures—Sociodemographic variables include age, gender, education, 
and paid work in the past 6 months. To assess HIV medication adherence, participants were 
asked to name all their HIV medications including antiretrovirals (ARVs) and drugs to 
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prevent opportunistic infections. Participants were then asked if they had missed a dose of 
each named medication in the past 30 days. Sexually transmitted infection (STI) symptoms 
were assessed by asking participants if they experienced one or more of the following 
symptoms in the past 6 months: abnormal discharge from the penis or vagina, sores in the 
genital area, or (for female patients only) lower abdominal pain. Participants were also asked 
if their health care provider discussed alcohol use with them during one of their clinic visits 
in the past 6 months.
To assess sexual risk behavior, participants were asked to name up to five partners with 
whom they had vaginal sex with in the past 3 months. For each named partner, participants 
were asked to classify the partner into one of three types: spouse (married or cohabitating 
partner), regular (a nonmarital, noncohabitating partner with whom participant has an 
ongoing relationship), or casual (a sexual partner with whom the participant has no ongoing 
relationship). Participants were asked if they had disclosed their HIV status to each named 
partner and if they knew that partner’s HIV status. For participants who reported more than 
one partner in the past 6 months, HIV status disclosure was restricted to the spouse or most 
recent main partner. If the participant did not report either a spouse or main partner, 
disclosure to non–main partner was used. Participants were dichotomized into two 
categories: those who knew their partner’s HIV status (partner was reported as either HIV-
positive or HIV-negative) and those who did not know their partner’s HIV status 
(participants who reported that their partner had not been tested; those who did not know if 
partner had been tested; and those whose partner had been tested but they did not know the 
partner’s status). Consistent condom use was examined for each named partner and was 
defined as using a condom at every reported sexual encounter in the past 3 months. Finally, 
participants were asked whether they had exchanged sex for a place to stay, money, food, or 
gifts in the past 6 months.
Health status variables abstracted from patients’ medical records include length of time 
since diagnosis, most recent CD4 count and date of test, and ART regimen (if any).
Data analysis
Descriptive statistics were computed for variables of interest overall and by gender. Gender 
differences were examined using the SAS GLIMMIX (SAS Institute, 2008) procedure with 
gender as the dependent variable and clinic as a random effect to control for correlation 
within clinic. A proportional odds model was used to explore the relationships of variables 
of interest with categories of alcohol use. Univariate and multiple proportional odds 
regression models were fit using PROC GLIMMIX (SAS Institute, 2008), with categories of 
alcohol use as the dependent variable and a random intercept for clinic, to account for 
within-clinic correlation. For each variable, we first tested the proportional odds assumption 
that the relationship between any two pairs of outcome groups was proportional (i.e., the 
null being that the odds were proportional across possible cutpoints applied to the three-level 
variable to create two categories and the alternative being that they were not proportional). 
For variables that met this assumption, one overall adjusted odds ratio (AOR) is presented. 
This odds ratio represents the odds of being in a higher risk category for drinking for the 
indicated group compared to the reference group. For variables that failed to meet this 
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assumption, AORs are presented for two dichotomous variables: (1) any drinking versus no 
drinking and (2) being categorized as a “harmful or likely dependent drinker” versus 
“nondrinker or nonharmful drinker.” To assess the relationship of binge drinking with 
variables of interest, mixed model univariate and multiple logistic regression models were fit 
using PROC GLIMMIX (SAS Institute, 2008) with a random intercept for clinic. For both 
models, all variables were entered into the model simultaneously, and associations were 
considered significant with a p value less than .05.
Results
A total of 3538 HIV-positive patients were enrolled. Table 1 presents a summary of 
participants’ characteristics, both overall and stratified by gender. The average age of 
participants was 37.2 years with male participants significantly older than female 
participants (40.8 years vs. 34.6 years, p < .0001). Most participants (61%) reported being 
married or cohabitating and most had completed a primary education or lower (63%). Only 
44% reported receiving any paid work during the past 6 months, with men significantly 
more likely to report this than women (55% vs. 37%, p < .0001). The majority of 
participants (69%) had learned of their HIV diagnosis within the past 3 years. The mean 
CD4 count for the sample was 373 cells/mm3 and was significantly higher for women than 
men (412 vs. 319 cells/mm3, p < .0001). Most participants (64%) were on ARV medications 
with men more likely to be on ARVs than women (72% vs. 59%, p < .0001).
Patient characteristics associated with categories of reported alcohol use
Overall, 20% of participants reported alcohol use in the past 6 months. Of these participants, 
15% were categorized as nonharmful drinkers and 5% were categorized as harmful or likely 
dependent drinkers. Table 2 presents participant characteristics associated with categories of 
reported alcohol use. Men were more likely to be categorized in the higher risk drinking 
categories than women [AOR: 2.20, 95% confidence interval (CI): 1.83, 2.63]. Participants 
who were not currently taking ARV medications (AOR: 1.37, 95% CI: 1.13, 1.67) or who 
reported missing a dose of their HIV medications (AOR: 2.04, 95% CI: 1.67, 2.49) were 
also more likely to be categorized in the higher risk drinking categories.
Similarly, participants who reported high-risk behaviors including inconsistent condom use 
(AOR: 1.49, 95% CI: 1.23, 1.79); exchanging sex for food, money, gifts, or a place to stay 
(AOR: 1.57, 95% CI: 1.06, 2.32); and having an STI symptom (AOR: 1.40, 95% CI: 1.10, 
1.77) were more likely to be categorized in the higher risk drinking categories. Additionally, 
participants who reported either multiple sex partners or casual sex partners in the past 90 
days were significantly more likely to report any drinking in the past 90 days (AOR: 2.38, 
95% CI: 1.66, 3.40; AOR: 1.54, 95% CI: 1.15, 2.06, respectively).
Patient characteristics associated with binge drinking
Overall, 5% of participants reported binge drinking in the past 30 days (Table 3). 
Participants from Kenya (AOR: 2.58, 95% CI: 1.38, 4.83) and Namibia (AOR: 4.46, 95% 
CI: 2.34, 8.52) were more likely to report binge drinking than participants from Tanzania. 
Other patient characteristics associated with binge drinking include being male (AOR: 2.30, 
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95% CI: 1.57, 3.38) and being diagnosed with HIV within the past year (AOR: 2.03, 95% 
CI: 1.22, 3.37). Binge drinking was also associated with missing an HIV medication dose 
(AOR: 2.11, 95% CI: 1.40, 3.17) and several high-risk behaviors including having multiple 
sex partners (AOR: 2.72, 95% CI: 1.54, 4.80), inconsistent condom use (AOR: 1.81, 95% 
CI: 1.25, 2.70), and reporting an STI symptom (AOR: 1.64, 95% CI: 1.03, 2.61).
Frequency of provider discussions with patients about their alcohol use
Overall, 79% of participants had discussed alcohol use with a health care provider in the 
past 6 months. Of these participants, 90% reported reducing their alcohol use as a result of 
this discussion (p < .0001). Participants categorized as harmful or likely dependent drinkers 
were more likely to report having this discussion with their provider (AOR: 1.42, 95% CI: 
1.14, 1.77).
Discussion
To our knowledge, this is one of the first studies to report the frequency of self-reported 
alcohol use among a large, multicountry, clinic-based sample of HIV-positive patients 
attending care in three SSA countries. Overall, 20% of the participants reported alcohol use 
in the past 6 months and 5% reported binge drinking. Fifteen percent were categorized as 
nonharmful drinkers and 5% as harmful or likely dependent drinkers. These frequencies are 
consistent with other studies of PLHIV attending clinical care conducted in Nigeria (Farley 
et al., 2010), South Africa (Myer et al., 2008), and Uganda (Hahn, Maier, Byakika-Tusiime, 
Oyugi, & Bangsberg, 2007) but lower than frequencies observed among the general 
population in SSA (WHO, 2004, 2011).
While ART has been clearly shown to reduce HIV incidence within serodiscordant couples 
(Cohen et al., 2011), the success of ART in achieving sustained reductions in viral load, and 
thus a reduction in infectiousness, depends upon long-term retention in care and medication 
adherence, two things inhibited by alcohol use. In this study, an association was observed 
between alcohol use and HIV medication nonadherence, with participants reporting 
incomplete adherence more likely to be categorized in the higher risk drinking categories. 
Participants who reported high-risk sexual behaviors were also more likely to be categorized 
in the higher risk drinking categories. These findings suggest that heavy alcohol use may 
impede the success of treatment as prevention efforts by increasing HIV risk behavior and 
decreasing HIV medication adherence.
In this baseline study, 79% of participants reported their provider had discussed alcohol use 
with them in the past 6 months and the vast majority of these participants (90%) reported 
that they changed their drinking behavior as a result of these discussions. While provider-
delivered alcohol reduction counseling has been shown to lead to a reduction in alcohol use 
among patients (Papas et al., 2011; Strauss et al., 2009), current screening activities are 
inadequate (Myer et al., 2008) and patients continue to perceive alcohol use to be low risk 
(Shacham, Hoffer, & Overton, 2011). As a result, it is possible that many patients with 
dangerous drinking behaviors are missed, particularly if the patient does not have an obvious 
comorbidity (Conigliaro, Gordon, McGinnis, Rabeneck & Justice, 2003). Failure to identify 
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these patients can lead to suboptimal management of HIV including treatment failure 
(Chander et al., 2006).
Many factors limit alcohol use screening including limited time, the social acceptability of 
alcohol use, and lack of training (Conigliaro et al., 2003; Shacham et al., 2011). However, 
given alcohol’s association with poor medication adherence and continued high-risk sexual 
behavior, it is essential that providers routinely screen their patients for current alcohol use 
and provide alcohol reduction counseling to those who report current use. Using lay 
counselors to assist health care providers in providing risk reduction counseling should be 
considered in settings where providers have limited time to provide in-depth counseling 
(Peltzer, Tabane, Matseke, & Simbayi, 2010). Patients reporting high-risk drinking 
behaviors should be referred to substance-abuse treatment programs, where available.
Individual-level counseling strategies must be accompanied by community- and structural-
level interventions, given the widespread availability of alcohol throughout SSA 
(Kalichman, 2007). These interventions can focus on changing the social norms around 
alcohol use (Kalichman et al., 2013) as well as changing legal and policy frameworks 
around alcohol use and substance-abuse treatment.
The results of this analysis should be interpreted in light of a number of limitations. All 
behavioral outcomes were based on patient self-report. These behaviors are influenced by 
social and cultural norms and are thus subject to a social desirability bias. Biomarker testing 
found that 15% of those starting ART in Uganda who reported no alcohol consumption had 
in fact engaged in heavy alcohol consumption in the past month (Hahn et al., 2010). Future 
studies on ART adherence and sexual risk behavior among PLHIV in SSA should consider 
using a biological marker to determine alcohol consumption (Hahn et al., 2011). Finally, the 
generalizability of these findings to PLHIV not enrolled in HIV clinical care and/or to 
PLHIV in nongeneralized epidemics may be limited.
Nevertheless, taken together with the results of other studies (Hahn et al., 2011; Woolf-King 
& Maisto, 2011), this research highlights the need to integrate alcohol screening and 
counseling into the adherence and risk reduction counseling offered to PLHIV as part of 
their routine care. Further operational research, ideally with biomarkers, is needed to 
determine the best models for screening patients for alcohol use and delivering targeted 
alcohol reduction counseling to patients reporting current alcohol use. Brief screening tools 
have been developed for use in high-resource settings and could potentially be adapted for 
use in low-resource settings (Kalichman et al., 2007). Moreover, given the numerous 
intersections between alcohol and HIV, policies and interventions that focus on reducing 
alcohol consumption and alcohol-related risk behavior should be integrated into HIV 
prevention, care, and treatment strategies (Fritz et al., 2010; Hahn et al., 2011).
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Table 1
Characteristics of PLHIV attending HIV clinical care in Namibia, Tanzania, and Kenya, study participants (n, 
%).
Overall (N = 3538) Male (n = 1484) Female (n = 2054) p value
Age (mean, SD) 37.2 (8.4) 40.8 (8.6) 34.6 (7.2) <0.0001
Country
 Namibia 1186 (33.5) 514 (34.6) 672 (32.7) 0.5139
 Tanzania 1196 (33.8) 479 (32.3) 717 (34.9)
 Kenya 1156 (32.7) 491 (33.1) 665 (32.4)
Current marital status
 Single/never married 781 (22.1) 268 (18.1) 513 (25.0) <0.0001
 Married/cohabitating as if married 2171 (61.4) 1031 (69.5) 1140 (55.6)
 Divorced/separated/widowed 584 (16.5) 185 (12.5) 399 (19.4)
Highest level of education completed
 None 340 (9.6) 148 (10.0) 192 (9.4)
 Primary 1890 (53.5) 787 (53.1) 1103 (53.8)
 Secondary 1215 (34.4) 502 (33.9) 713 (34.8)
 More than secondary 88 (2.5) 45 (3.0) 43 (2.1) 0.2542
Paid work in the last 6 months
 No 1967 (55.7) 667 (45.0) 1300 (63.4)
 Yes 1566 (44.3) 815 (55.0) 751 (36.6) <0.0001
Currently on anti-retroviral medications
 No 1266 (35.8) 418 (28.2) 848 (41.3)
 Yes 2271 (64.2) 1066 (71.8) 1205 (58.7) <0.0001
Time since HIV diagnosis
 <1 year 925 (26.2) 406 (27.4) 519 (25.3)
 1 to 2 years 807 (22.8) 331 (22.3) 476 (23.2)
 2 to <3 years 723 (20.5) 311 (21.0) 412 (20.1)
 ≥3 years 1081 (30.6) 434 (29.3) 647 (31.5) 0.2253
CD4 count (mean, SD) 373.4 (237.5) 319.3 (204.6) 412.3 (251.5) <0.0001
Note: Counts may not add to the total due to missing data.
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